Found: 66
Select item for more details and to access through your institution.
Insertion of drug resistance genes in animals.
- Published in:
- Journal of Cellular Physiology, 1982, v. 113, p. 213, doi. 10.1002/jcp.1041130429
- By:
- Publication type:
- Article
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.
- Published in:
- Nature, 1982, v. 299, n. 5884, p. 640, doi. 10.1038/299640a0
- By:
- Publication type:
- Article
Expression of the nm23 Gene and Breast Cancer Prognosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 4, p. 229
- By:
- Publication type:
- Article
A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01).
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 307, doi. 10.3816/CBC.2010.n.040
- By:
- Publication type:
- Article
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.
- Published in:
- EMBO Journal, 1998, v. 17, n. 11, p. 3052, doi. 10.1093/emboj/17.11.3052
- By:
- Publication type:
- Article
Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 2, p. 3094, doi. 10.3390/ijms14023094
- By:
- Publication type:
- Article
Pleiotrophin mediates hematopoietic regeneration via activation of RAS.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 11, p. 4753, doi. 10.1172/JCI76838
- By:
- Publication type:
- Article
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Mesenchymal gene program--expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 6, p. 2611, doi. 10.1172/JCI69815
- By:
- Publication type:
- Article
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 23, doi. 10.1007/s10549-020-05782-4
- By:
- Publication type:
- Article
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18).
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 2, p. 419, doi. 10.1007/s10549-020-05755-7
- By:
- Publication type:
- Article
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 3, p. 617, doi. 10.1007/s10549-019-05198-9
- By:
- Publication type:
- Article
Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the her-2/ neu oncogene.
- Published in:
- International Journal of Cancer, 1991, v. 47, n. 1, p. 66, doi. 10.1002/ijc.2910470113
- By:
- Publication type:
- Article
Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues.
- Published in:
- International Journal of Cancer, 1990, v. 45, n. 3, p. 457, doi. 10.1002/ijc.2910450314
- By:
- Publication type:
- Article
Oncogenes: Implications for the Diagnosis and Treatment of Cancer.
- Published in:
- Annals of Internal Medicine, 1984, v. 101, n. 2, p. 223, doi. 10.7326/0003-4819-101-2-223
- By:
- Publication type:
- Article
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231178125
- By:
- Publication type:
- Article
Cyclin D1 Amplification and p16(MTS1/CDK4I) Deletion Correlate With Poor Prognosis in Head and Neck Tumors.
- Published in:
- Laryngoscope, 2002, v. 112, n. 3, p. 472, doi. 10.1097/00005537-200203000-00013
- By:
- Publication type:
- Article
Expression of c-Fes Protein Isoforms Correlates with Differentiation in Myeloid Leukemias.
- Published in:
- DNA & Cell Biology, 2005, v. 24, n. 5, p. 311, doi. 10.1089/dna.2005.24.311
- By:
- Publication type:
- Article
Spatial and Temporal Changes in the Subcellular Localization of the Nuclear Protein–Tyrosine Kinase, c-Fes.
- Published in:
- DNA & Cell Biology, 2005, v. 24, n. 4, p. 225, doi. 10.1089/dna.2005.24.225
- By:
- Publication type:
- Article
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-157
- By:
- Publication type:
- Article
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-022-01587-z
- By:
- Publication type:
- Article
Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
- Published in:
- Human Genetics, 2008, v. 123, n. 1, p. 55, doi. 10.1007/s00439-007-0449-5
- By:
- Publication type:
- Article
A careful reassessment of anthracycline use in curable breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00342-5
- By:
- Publication type:
- Article
Evolving Understanding of Growth Regulation in Human Breast Cancer: Interactions of the Steroid and Peptide Growth Regulatory Pathways.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 15, p. 1141, doi. 10.1093/jnci/djh198
- By:
- Publication type:
- Article
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Is there a role for epidermal growth factor receptor inhibitors in breast cancer prevention?
- Published in:
- 2003
- By:
- Publication type:
- Editorial
RESPONSE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2003, v. 95, n. 18, p. 1418
- By:
- Publication type:
- Article
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Clinical evaluation of BCL-2/X<sub>L</sub> levels pre- and post- HER2-targeted therapy.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0251163
- By:
- Publication type:
- Article
A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases.
- Published in:
- 1991
- By:
- Publication type:
- journal article
INSERTION OF NEW GENETIC INFORMATION INTO BONE MARROW CELLS OF MICE: COMPARISON OF TWO SELECTABLE GENES*.
- Published in:
- Annals of the New York Academy of Sciences, 1982, v. 397, n. 1, p. 272, doi. 10.1111/j.1749-6632.1982.tb43434.x
- By:
- Publication type:
- Article
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
- Published in:
- Oncogene, 1999, v. 18, n. 44, p. 6050, doi. 10.1038/sj.onc.1202993
- By:
- Publication type:
- Article
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
- Published in:
- Oncogene, 1998, v. 17, n. 17, p. 2235, doi. 10.1038/sj.onc.1202132
- By:
- Publication type:
- Article
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
- Published in:
- Oncogene, 1997, v. 15, n. 5, p. 537, doi. 10.1038/sj.onc.1201222
- By:
- Publication type:
- Article
Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b.
- Published in:
- Oncogene, 1997, v. 14, n. 1, p. 1, doi. 10.1038/sj.onc.1200924
- By:
- Publication type:
- Article
Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells.
- Published in:
- Nucleic Acids Research, 1999, v. 27, n. 20, p. 4008
- By:
- Publication type:
- Article
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918807339
- By:
- Publication type:
- Article
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Integrative transcriptomics and cell systems analyses reveal protective pathways controlled by Igfbp‐3 in anthracycline‐induced cardiotoxicity.
- Published in:
- FASEB Journal, 2023, v. 37, n. 6, p. 1, doi. 10.1096/fj.202201885RR
- By:
- Publication type:
- Article
A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: A clinical and molecular analysis.
- Published in:
- American Journal of Hematology, 1989, v. 30, n. 3, p. 128, doi. 10.1002/ajh.2830300304
- By:
- Publication type:
- Article
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 6, p. 1049, doi. 10.1002/ijc.21250
- By:
- Publication type:
- Article
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.
- Published in:
- British Journal of Cancer, 2019, v. 121, n. 4, p. 318, doi. 10.1038/s41416-019-0517-3
- By:
- Publication type:
- Article
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 8, p. 589, doi. 10.1002/gcc.22459
- By:
- Publication type:
- Article
ADRM1-amplified metastasis gene in gastric cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 8, p. 506, doi. 10.1002/gcc.22262
- By:
- Publication type:
- Article